Canlyniadau Chwilio

Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB gan Christiane Gerke, Anna Colucci, Carlo Giannelli, Silvia Sanzone, Claudia Giorgina Vitali, Luigi Sollai, Omar Rossi, Laura B. Martin, Jochen Auerbach, Vito Di Cioccio, Allan Saul

Cael y testun llawn Cael y testun llawn

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting gan Adam Penn‐Nicholson, Hennie Geldenhuys, Wivine Burny, Robbert van der Most, Cheryl L. Day, Erik Jongert, Philippe Moris, Mark Hatherill, Opokua Ofori‐Anyinam, Willem A. Hanekom, Anne Bollaerts, Marie‐Ange Demoitié, Angelique Kany Kany Luabeya, Evi De Ruymaeker, Michèle Tameris, Didier Lapierre, Thomas J. Scriba

Cael y testun llawn

Application of “Systems Vaccinology” to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines gan D. J. Lewis, Mark P. Lythgoe

Cael y testun llawn Cael y testun llawn

Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study gan Kirsten P. Perrett, Jodie McVernon, Peter Richmond, Helen Marshall, Michael D. Nissen, Allison August, Sandra Percell, Daniela Toneatto, Terry Nolan

Cael y testun llawn

Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults gan Manon Cox, Ruvim Izikson, Penny Post, Lisa M. Dunkle

Cael y testun llawn Cael y testun llawn

Safety and immunogenicity of an investigational 4-component<i>Staphylococcus aureus</i>vaccine with or without AS03_Badjuvant: Results of a randomized phase I trial gan Jack Lévy, Laurent Licini, Edwige Haelterman, Philippe Moris, Pascal Lestrate, Silvia Damaso, Pascale Van Belle, Dominique Boutriau

Cael y testun llawn Cael y testun llawn

Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial gan Remigio M. Olveda, Luz P. Acosta, Veronica Tallo, Palmera Baltazar, Jenny Lind S Lesiguez, Georgette G Estanislao, Edna B. Ayaso, Donna Bella S. Monterde, Antonio Ida, Nora L. Watson, Emily A. McDonald, Hannah Wu, Jonathan D. Kurtis, Jennifer F. Friedman

Cael y testun llawn

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs gan Nikolai Petrovsky

Cael y testun llawn Cael y testun llawn

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in gi... gan Ting Fan Leung, Anthony Pak‐Yin Liu, Fong Seng Lim, Franck Thollot, Helen May Lin Oh, Bee Wah Lee, Lars Rombo, Ngiap Chuan Tan, Roman Rouzier, Damien Friel, Benoit De Muynck, Stéphanie De Simoni, P.V. Suryakiran, Marjan Hezareh, Nicolas Folschweiller, Florence Thomas, Frank Struyf

Cael y testun llawn Cael y testun llawn

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I) gan Roman Prymula, Susanna Esposito, Gian Vincenzo Zuccotti, Fang Xie, Daniela Toneatto, Igor Kohl, Peter Dull

Cael y testun llawn

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children gan Sodiomon B. Sirima, Alfred B. Tiono, Alphonse Ouédraogo, Amidou Diarra, André Lin Ouédraogo, Jean Baptiste Yaro, Espérance Ouédraogo, Adama Gansané, Edith C. Bougouma, Amadou T. Konaté, Youssouf Kaboré, Abdoulaye Traoré, Roma Chilengi, Issiaka Soulama, Adrian J. F. Luty, Simon Cousens, Issa Nébié

Cael y testun llawn Cael y testun llawn

Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate gan Jeffrey R. Currier, Viseth Ngauy, Mark de Souza, Silvia Ratto‐Kim, Josephine H. Cox, Victoria R. Polonis, Patricia L. Earl, Bernard Moss, Sheila A. Peel, Bonnie M. Slike, Somchai Sriplienchan, P Thongcharoen, Robert Paris, Merlin L. Robb, Jérôme H. Kim, Nelson L. Michael, Mary Marovich

Cael y testun llawn Cael y testun llawn

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study gan Geert Leroux‐Roels, Cathy Maes, Fien De Boever, Magali Traskine, J. Rüggeberg, Dorota Borys

Cael y testun llawn

A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720 gan James McCarthy, Joanne Marjason, Suzanne Elliott, Paul Fahey, Gilles Bang, Elissa Malkin, E L Tierney, Hayley Aked-Hurditch, Christopher G. Adda, Nadia Cross, Jack S. Richards, Freya J. I. Fowkes, Michelle J. Boyle, Carole A. Long, Pierre Druilhe, James G. Beeson, Robin F. Anders

Cael y testun llawn Cael y testun llawn

Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans gan Ming Qiao, David R. Shaw, Rémi Forrat, Anh Wartel-Tram, Jean Lang

Cael y testun llawn Cael y testun llawn

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial gan Paul Spearman, Spyros A. Kalams, Marnie Elizaga, Barbara Metch, Ya-Lin Chiu, Mary Allen, Kent J. Weinhold, Guido Ferrari, Scott Parker, M. Juliana McElrath, Sharon E. Frey, Jonathan Fuchs, Michael C. Keefer, Michael D. Lubeck, Michael A. Egan, Ralph P. Braun, John H. Eldridge, Barton F. Haynes, Lawrence Corey

Cael y testun llawn

Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial gan David J. Holland, Robert Booy, Ferdinandus de Looze, Peter Eizenberg, James McDonald, Jeff Karrasch, Maureen McKeirnan, Hatem H. Salem, Graham Mills, Jim Reid, Françoise Weber, Mélanie Saville

Cael y testun llawn Cael y testun llawn

Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand gan Punnee Pitisuttithum, Supachai Rerks‐Ngarm, Valai Bussaratid, Jittima Dhitavat, Wirach Maek-a-nantawat, Swangjai Pungpak, Pravan Suntharasamai, S Vanijanonta, Sorachai Nitayapan, Jaranit Kaewkungwal, Michael W. Benenson, Patricia Morgan, Robert J. O’Connell, Jeffrey L. Berenberg, Sanjay Gurunathan, Donald P. Francis, Robert Paris, Joseph Chiu, Donald M. Stablein, Nelson L. Michael, Jean‐Louis Excler, Merlin L. Robb, Jérôme H. Kim

Cael y testun llawn Cael y testun llawn

Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type... gan E Hayton, Annie Rose, Umar Ibrahimsa, Mariarosaria Del Sorbo, Stefania Capone, Alison Crook, Antony P. Black, Lucy Dorrell, Tomáš Hanke

Cael y testun llawn Cael y testun llawn

High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants gan Xinyuan Chen, Marco Pravetoni, Brijesh Bhayana, Paul R. Pentel, Mei X. Wu

Cael y testun llawn